TOP NEWS: AstraZeneca's Lynparza approved in China for ovarian cancer
eneca PLC on
Thursday, along with pharmaceutical peer Merck & Co Inc, said
that Lynparza has been approved in China for the maintenance
Subscribe now to see this Premium News
Alliance News Professional covers every UK
stock in your portfolio. It goes beyond regulatory news and free
web services to give your investment decisions an edge over the
- In The
Know - Management and analyst comments that go beyond company
- Flash headlines on all 2,400 London-listed companies before the
news hits the open web.
- Broker Ratings - The
earliest tip-offs, many before the market opens.
- Economic data and central bank flashes from UK, US and
AIM - Up to the minute market commentary on AIM stocks.
- Over 500 news items per trading day for just £39.60 per month,
and cancel at any time.
Call us on +44 (0) 203 8794 460 to get
から 10 2022 まで 11 2022
から 11 2021 まで 11 2022